TCR-mimic bispecific nanobody-based T cell engager targeting intracellular tumor antigens for cancer immunotherapy

Abstract T cell engager (TCE) immunotherapies have revolutionized the landscape of cancer treatment; however, their efficacy remains limited by the inaccessibility of intracellular tumor antigens. Conventional bispecific T cell engagers, typically constructed from aggregation-prone single-chain vari...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Ziqiang Ding, Shuyang Sun, Xiaomei Yang, Xianing Huang, Xiaoqiong Hou, Shenxia Xie, Aiqun Liu, Xiaoling Lu
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Nature Publishing Group 2026-06-01
Reeks:	Signal Transduction and Targeted Therapy
Online toegang:	https://doi.org/10.1038/s41392-026-02745-x
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!